Heparin-bonded Dacron or polytetrafluorethylene for femoropopliteal bypass: Five-year results of a prospective randomized multicenter clinical trial

Slides:

Advertisements

Similar presentations

Jeffrey P. Carpenter, MD, John E. Tomaszewski, MD

Advertisements

Four years' results of a prospective, randomized clinical trial comparing polytetrafluoroethylene and modified human umbilical vein for below-knee femoropopliteal.

Antiplatelet drugs in femoropopliteal vein bypasses: A multicenter trial Charles McCollum, MB, ChB, MD, FRCS, Christine Alexander, Dip N, Glenda Kenchington,

Richard M. Green, MD, William M

Without prejudice Journal of Vascular Surgery

Lloyd M. Taylor, M.D., Edward S. Phinney, M.D., John M. Porter, M.D.

Peter J. Fahner, MD, Mirza M. Idu, MD, PhD, Thomas M

Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia Louis L. Nguyen,

Flow measurement before and after papaverine injection in above-knee prosthetic femoropopliteal bypass Gustav Pedersen, MD, Elin Laxdal, MD, Svein Roar.

Outcome of infra-inguinal bypass grafts using vein conduit with less than 3 millimeters diameter in critical leg ischemia Hani Slim, MD, MRCS, Alok Tiwari,

Endovascular treatment of long lesions of the superficial femoral artery: Results from a multicenter registry of a spiral, covered polytetrafluoroethylene.

The current position of precuffed expanded polytetrafluoroethylene bypass grafts in peripheral vascular surgery Jasper van der Slegt, MD, Stijn L. Steunenberg,

Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial Jill.

Axillofemoral bypass: A tool with a limited role

The impact of gender on outcome after infrainguinal arterial reconstructions for peripheral occlusive disease Enzo Ballotta, MD, Mario Gruppo, MD, Renata.

LEA 25. Outcomes in Limb Preservation After Revascularization and Minor Amputations in 876 Patients With Peripheral Arterial Disease During a 9-Year Period

Statin therapy is associated with superior clinical outcomes after endovascular treatment of critical limb ischemia Francesco A. Aiello, MD, Asad A.

Cryopreserved arterial allograft reconstruction for peripheral graft infection Yves Castier, MD, Fady Francis, MD, Pierre Cerceau, MD, Mathieu Besnard,

Without prejudice Journal of Vascular Surgery

Percutaneous transluminal angioplasty for the treatment of limb threatening ischemia: Do the results justify an attempt before bypass grafting? Richard.

Axillopopliteal bypass for limb salvage

Edmond J. Prendiville, MB, FRCSI, Anson Yeager, MD, Thomas F

Early complications and long-term outcome after open surgical treatment of popliteal artery aneurysms: Is exclusion with saphenous vein bypass still the.

Infrainguinal revascularizations in octogenarians and septuagenarians

Thrombolysis for lower extremity bypass graft occlusion

Cryopreserved saphenous vein graft in infrainguinal bypass

Peripheral atherectomy with the rotablator: A multicenter report

Results of PREVENT III: A multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery Michael.

Optimal conduit choice in the absence of single-segment great saphenous vein for below-knee popliteal bypass James T. McPhee, MD, Neal R. Barshes, MD,

Five-Year Patency Rates for Heparin-Bonded Expanded Polytetrafluoroethylene Femoropopliteal Bypass Grafts vs ePTFE Grafts Without Heparin Russell H.

A prospective randomized trial comparing vein with polytetrafluoroethylene in above- knee femoropopliteal bypass grafting Desiree H.C. Burger, MDa, A.Pieter.

Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial.

Syed N. Haider, Eamon G. Kavanagh, MD, Martin Forlee, FCS (SA), Mary P

Lower extremity arterial reconstruction for critical limb ischemia in diabetes Enzo Ballotta, MD, Antonio Toniato, MD, Giacomo Piatto, MD, Franco Mazzalai,

Tibial bypass grafting for limb salvage with ringed polytetrafluoroethylene prostheses: Results of primary and secondary procedures Hans Schweiger, MD,

Pedal bypass surgery after crural endovascular intervention

A personal experience with the influence of diabetes and other factors on the outcome of infrainguinal bypass grafts for occlusive disease Norman R.

Primary anastomotic bonding in polytetrafluoroethylene grafts?

A multicenter comparison between autologous saphenous vein and heparin-bonded expanded polytetrafluoroethylene (ePTFE) graft in the treatment of critical.

Long-term outcome after early infrainguinal graft failure

Toshifumi Kudo, MD, PhD, Fiona A. Chandra, Samuel S. Ahn, MD

Prospective, randomized comparison of ringed and nonringed polytetrafluoroethylene femoropopliteal bypass grafts: A preliminary report Sushil K. Gupta,

Antonio V. Sterpetti, M. D. , Richard D. Schultz, M. D. , Richard J

Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease Hasan H.

Meta-analysis of femoropopliteal bypass grafts for lower extremity arterial insufficiency Carlos Eduardo Pereira, MD, Maximiano Albers, MD, PhD, Marcello.

Peripheral atherectomy in TransAtlantic InterSociety Consensus type C femoropopliteal lesions for limb salvage Andrea E. Yancey, MD, David J. Minion,

The consequences of a failed femoropopliteal bypass grafting: Comparison of saphenous vein and PTFE grafts Mark R. Jackson, MDa, Todd P. Belott, MDa,

Long-term assessment of cryopreserved vein bypass grafting success

Using the diamond intermediate anastomosis in composite sequential bypass grafting for critical limb ischemia Ailín C. Rogers, PhD, Paul W. Reddy, MBBCh.

Composite sequential bypasses to the ankle and beyond for limb salvage

Carlos H. Timaran, MD, Scott L. Stevens, MD, Oscar H

Compromised bypass graft outcomes after minimal-incision vein harvest

Distal vein patch with an arteriovenous fistula: A viable option for the patient without autogenous conduit and severe distal occlusive disease Richard.

Gregory C. Schmieder, MD, Megan Carroll, BA, BS, Jean M. Panneton, MD

Regarding “Vascular abnormalities in patients with neurofibromatosis syndrome type I: Clinical spectrum, management, and results” John B. Chang, MD,

Antiplatelet drugs in femoropopliteal vein bypasses: A multicenter trial Charles McCollum, MB, ChB, MD, FRCS, Christine Alexander, Dip N, Glenda Kenchington,

James E. Edwards, MD, Lloyd M. Taylor, MD, John M. Porter, MD

Polytetrafluoroethylene versus human umbilical vein in above-knee femoropopliteal bypass: Six-year results of a randomized clinical trial Gijs J. Aalders,

Surgical management of severe acute lower extremity ischemia

Isolated profundaplasty for limb salvage

Prospective randomized study on bilateral above-knee femoropopliteal revascularization: polytetrafluoroethylene graft versus reversed saphenous vein

Heparin-bonded expanded polytetrafluoroethylene femoropopliteal bypass grafts outperform expanded polytetrafluoroethylene grafts without heparin in a.

Peter G. Kalman, M. D. , Marilyn Hosang, R. N. , Claudio Cina, M. D

Secondary aortoenteric fistula: Contemporary outcome with use of extraanatomic bypass and infected graft excision Laurie M. Kuestner, MD, Linda M. Reilly,

Long-term results of arterial allograft below-knee bypass grafts for limb salvage: A retrospective multicenter study J.N. Albertini, MD, X. Barral, MD,

Luke S. Erdoes, MD, Timothy P. Milner, MD Journal of Vascular Surgery

Benjamin B. Chang, MD, R. Clement Darling, MD, Devon E. M

Four years' results of a prospective, randomized clinical trial comparing polytetrafluoroethylene and modified human umbilical vein for below-knee femoropopliteal.

Factors associated with primary vein graft occlusion in a multicenter trial with mandated ultrasound surveillance Lawrence Oresanya, MD, Anil N. Makam,

Scott M. Surowiec, MD, Mark G. Davies, MD, PhD, Shirley W

Presentation transcript:

Heparin-bonded Dacron or polytetrafluorethylene for femoropopliteal bypass: Five-year results of a prospective randomized multicenter clinical trial Carol Devine, BA, Charles McCollum, MD, FRCS Journal of Vascular Surgery Volume 40, Issue 5, Pages 924-931 (November 2004) DOI: 10.1016/j.jvs.2004.08.033 Copyright © 2004 The Society for Vascular Surgery Terms and Conditions

Fig 1 Primary patency at life table analysis for heparin-bonded Dacron (HBD) was 71%, 54%, and 46%, respectively, for years 1, 3, and 5, compared with 62%, 44%, and 35% for polytetrafluoroethylene (PTFE). Journal of Vascular Surgery 2004 40, 924-931DOI: (10.1016/j.jvs.2004.08.033) Copyright © 2004 The Society for Vascular Surgery Terms and Conditions

Fig 2 A, Primary patency of above-knee grafts was 76%, 59%, and 50%, respectively, for heparin-bonded Dacron (HBD) at years 1, 3, and 5, compared with 66%, 49%, and 41% for polytetrafluoroethylene (PTFE). B, Results were uniformly poor for below-knee bypass. Journal of Vascular Surgery 2004 40, 924-931DOI: (10.1016/j.jvs.2004.08.033) Copyright © 2004 The Society for Vascular Surgery Terms and Conditions

Fig 3 Cumulative limb salvage at 5 years was 86% for heparin-bonded Dacron (HBD) and 74% for polytetrafluoroethylene (PTFE). Journal of Vascular Surgery 2004 40, 924-931DOI: (10.1016/j.jvs.2004.08.033) Copyright © 2004 The Society for Vascular Surgery Terms and Conditions